[Changes of the biohumoral picture in alcoholic hepatopathy treated with thiazolidinecarboxylate of arginine].
In 28 patients suffering from alcoholic well compensated hepatopathy, different laboratory parameters have been controlled before and after treatment with arginine thiazolidinecarboxylate, i.v. a the daily dose of 800 mg for 7-10 days. The compartmental analysis showed that the improvement in the BSF clearance is mainly due to a reduction in the "regurgitation fraction" and therefore to an improvement or restoration of the processes of conjugation, binding and transferring of the dye in the liver cells. A significant increase in platelets and an equally significant decrease in bilirubinemia, gamma GT, OCT, GOT and alkaline phosphatase were reported. Such variations might be at any rate due to the sole alcohol abstinence. The observed increase in transferrin, haptoglobin and albumin cannot be reported to the sole abstinence, but must be considered as consequence of the pharmacological influence, of arginine thiazolidinecarboxylate on the protidosynthetic activities of the liver.
D001120:Arginine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D001663:Bilirubin / Q000097:blood; D001798:Blood Proteins / Q000032:analysis; D006242:Haptoglobins / Q000032:analysis; D006801:Humans; D008108:Liver Diseases, Alcoholic / Q000188:drug therapy*; D053778:Thiazolidines; D000637:Transaminases / Q000097:blood; D014168:Transferrin / Q000032:analysis; D005723:gamma-Glutamyltransferase / Q000097:blood
D001798:Blood Proteins; D006242:Haptoglobins; D053778:Thiazolidines; D014168:Transferrin; C020213:arginine thiazolidinecarboxylate; D001120:Arginine; D005723:gamma-Glutamyltransferase; D000637:Transaminases; D001663:Bilirubin
Variazioni del quadro bioumorale della epatopatia etilica trattata con tiazolidincarbossilato di arginina.